BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 25042708)

  • 1. Switches of hydrogen bonds during ligand-protein association processes determine binding kinetics.
    Huang YM; Kang M; Chang CE
    J Mol Recognit; 2014 Sep; 27(9):537-48. PubMed ID: 25042708
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ritonavir and xk263 Binding-Unbinding with HIV-1 Protease: Pathways, Energy and Comparison.
    Sun J; Raymundo MAV; Chang CA
    Life (Basel); 2022 Jan; 12(1):. PubMed ID: 35054509
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mechanism of the Association Pathways for a Pair of Fast and Slow Binding Ligands of HIV-1 Protease.
    Huang YM; Raymundo MA; Chen W; Chang CA
    Biochemistry; 2017 Mar; 56(9):1311-1323. PubMed ID: 28060481
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Binding pathways of ligands to HIV-1 protease: coarse-grained and atomistic simulations.
    Chang CE; Trylska J; Tozzini V; McCammon JA
    Chem Biol Drug Des; 2007 Jan; 69(1):5-13. PubMed ID: 17313452
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gating and Intermolecular Interactions in Ligand-Protein Association: Coarse-Grained Modeling of HIV-1 Protease.
    Kang M; Roberts C; Cheng Y; Chang CE
    J Chem Theory Comput; 2011 Oct; 7(10):3438-46. PubMed ID: 26598172
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Strength of hydrogen bond network takes crucial roles in the dissociation process of inhibitors from the HIV-1 protease binding pocket.
    Li D; Ji B; Hwang KC; Huang Y
    PLoS One; 2011 Apr; 6(4):e19268. PubMed ID: 21559397
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structural and binding insights into HIV-1 protease and P2-ligand interactions through molecular dynamics simulations, binding free energy and principal component analysis.
    Karnati KR; Wang Y
    J Mol Graph Model; 2019 Nov; 92():112-122. PubMed ID: 31351319
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Binding free energy contributions of interfacial waters in HIV-1 protease/inhibitor complexes.
    Lu Y; Yang CY; Wang S
    J Am Chem Soc; 2006 Sep; 128(36):11830-9. PubMed ID: 16953623
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Coarse-grained molecular dynamics of ligands binding into protein: The case of HIV-1 protease inhibitors.
    Li D; Liu MS; Ji B; Hwang K; Huang Y
    J Chem Phys; 2009 Jun; 130(21):215102. PubMed ID: 19508101
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ligand Binding Pathways and Conformational Transitions of the HIV Protease.
    Miao Y; Huang YM; Walker RC; McCammon JA; Chang CA
    Biochemistry; 2018 Mar; 57(9):1533-1541. PubMed ID: 29394043
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular dynamics simulations applied to the study of subtypes of HIV-1 protease common to Brazil, Africa, and Asia.
    Batista PR; Wilter A; Durham EH; Pascutti PG
    Cell Biochem Biophys; 2006; 44(3):395-404. PubMed ID: 16679526
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Protein-ligand interfaces are polarized: discovery of a strong trend for intermolecular hydrogen bonds to favor donors on the protein side with implications for predicting and designing ligand complexes.
    Raschka S; Wolf AJ; Bemister-Buffington J; Kuhn LA
    J Comput Aided Mol Des; 2018 Apr; 32(4):511-528. PubMed ID: 29435780
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multi-drug resistance profile of PR20 HIV-1 protease is attributed to distorted conformational and drug binding landscape: molecular dynamics insights.
    Chetty S; Bhakat S; Martin AJ; Soliman ME
    J Biomol Struct Dyn; 2016; 34(1):135-51. PubMed ID: 25671669
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Insights into the dynamics of HIV-1 protease: a kinetic network model constructed from atomistic simulations.
    Deng NJ; Zheng W; Gallicchio E; Levy RM
    J Am Chem Soc; 2011 Jun; 133(24):9387-94. PubMed ID: 21561098
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular dynamic and free energy studies of primary resistance mutations in HIV-1 protease-ritonavir complexes.
    Aruksakunwong O; Wolschann P; Hannongbua S; Sompornpisut P
    J Chem Inf Model; 2006; 46(5):2085-92. PubMed ID: 16995739
    [TBL] [Abstract][Full Text] [Related]  

  • 16. How Mutations Can Resist Drug Binding yet Keep HIV-1 Protease Functional.
    Appadurai R; Senapati S
    Biochemistry; 2017 Jun; 56(23):2907-2920. PubMed ID: 28505418
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Substrate binding mechanism of HIV-1 protease from explicit-solvent atomistic simulations.
    Pietrucci F; Marinelli F; Carloni P; Laio A
    J Am Chem Soc; 2009 Aug; 131(33):11811-8. PubMed ID: 19645490
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analysis of structural water and CH···π interactions in HIV-1 protease and PTP1B complexes using a hydrogen bond prediction tool, HBPredicT.
    Yesudas JP; Sayyed FB; Suresh CH
    J Mol Model; 2011 Feb; 17(2):401-13. PubMed ID: 20490879
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Analysis of Ligand-Receptor Association and Intermediate Transfer Rates in Multienzyme Nanostructures with All-Atom Brownian Dynamics Simulations.
    Roberts CC; Chang CE
    J Phys Chem B; 2016 Aug; 120(33):8518-31. PubMed ID: 27248669
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ligand conformational and solvation/desolvation free energy in protein-ligand complex formation.
    Kolár M; Fanfrlík J; Hobza P
    J Phys Chem B; 2011 Apr; 115(16):4718-24. PubMed ID: 21466174
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.